Non-proprietary assay (NPA) / generic analysis
Non-proprietary assay (NPA)/generic analysis allows for development of new therapeutic agents and testing that can be tailor-made to suit individual client purposes. Assay developers can determine an appropriate sample size based on estimates of the outcome being investigated be it performance, accuracy or appropriateness for intended use. The nature of NPA/generic analysis can significantly reduce assay development efforts and lead to shorter preparation time.